Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices Offering of Euro-denominated Senior Notes

NEW YORK(GenomeWeb) – Thermo Fisher Scientific on Monday after the close of the market priced its offering of €640 million ($797 million) of 2 percent senior notes due 2025 at an issue price of 99.68 percent of the principal amount.  

The issuance of the notes is expected to close on or about Nov. 24. The company plans to use net proceeds mainly to repay about $70 million of short-term indebtedness and to repay about $600 million of long-term indebtedness, which consists of outstanding amounts under the company's $5 billion term loan.  

Thermo Fisher filed a prospectus for the euro-denominated offering of the senior notes last week. On Friday, the company issued $800 million in aggregate principal amount of 3.3 percent senior notes due in 2022. 

The joint book-running managers on the offering are HSBC Bank, Deutsche Bank Securities, and RBS Securities.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.